ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 73 filers reported holding ACELRX PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.72 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $14,000 | -82.3% | 65,333 | +41.5% | 0.00% | – |
| Q1 2021 | $79,000 | -38.8% | 46,180 | -56.7% | 0.00% | -100.0% |
| Q2 2020 | $129,000 | +143.4% | 106,580 | +321.6% | 0.00% | – |
| Q4 2019 | $53,000 | -78.6% | 25,280 | -64.5% | 0.00% | -100.0% |
| Q1 2019 | $248,000 | -80.8% | 71,144 | -87.3% | 0.00% | -80.0% |
| Q4 2018 | $1,292,000 | +452.1% | 559,408 | +820.9% | 0.01% | +400.0% |
| Q3 2018 | $234,000 | +588.2% | 60,744 | +455.6% | 0.00% | – |
| Q1 2016 | $34,000 | -79.3% | 10,934 | -74.3% | 0.00% | -100.0% |
| Q4 2015 | $164,000 | -72.7% | 42,531 | -14.9% | 0.00% | -66.7% |
| Q1 2014 | $600,000 | – | 49,976 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 6,574,060 | $27,874,000 | 1.68% |
| SENZAR ASSET MANAGEMENT, LLC | 798,381 | $3,385,000 | 0.58% |
| Cormorant Asset Management, LP | 850,000 | $3,604,000 | 0.48% |
| Palo Alto Investors LP | 2,135,739 | $9,056,000 | 0.40% |
| Opus Point Partners Management, LLC | 99,959 | $424,000 | 0.34% |
| Granahan Investment Management | 1,582,237 | $6,709,000 | 0.19% |
| Joel Isaacson & Co., LLC | 70,660 | $300,000 | 0.08% |
| MARINER INVESTMENT GROUP LLC | 59,700 | $253,000 | 0.06% |
| MYCIO WEALTH PARTNERS, LLC | 75,000 | $318,000 | 0.06% |
| Cornerstone Capital, Inc. | 59,200 | $251,000 | 0.06% |